-transparent.png){kind=logo}
A case-control study was done to test the effect of serum dopamine-beta-hydroxylase (DBH) activity on tardive dyskinesia (TD) among 85 schizophrenic outpatients treated with neuroleptics. In contrast to the results of several previous studies, we found no significant association between serum DBH activity and the occurrence or severity of TD, controlling for other TD predictors.
Related Publications
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
October 1979,
Lancet (London, England),
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
March 1983,
Biological psychiatry,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
March 1971,
Circulation research,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
July 1998,
Indian journal of psychiatry,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
September 1976,
Archives of neurology,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
May 1972,
The New England journal of medicine,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
October 1980,
Biological psychiatry,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
March 1978,
Psychosomatic medicine,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
June 1977,
Mayo Clinic proceedings,
W M Glazer, and
H Morgenstern, and
D V Jeste, and
G Zahner, and
H M Hafez, and
C L Benarroche
October 1977,
The American journal of psychiatry,
